a new biotech drug for Crohn's disease called Remicade (infliximab)

You'll see a new biotech drug for Crohn's disease called Remicade (infliximab)...from Schering Canada.

It's a monoclonal antibody that neutralizes the activity of tumour necrosis factor...a protein that promotes inflammation.

Remicade reduces symptoms in up to 80% of patients with moderate to severe Crohn's that's resistant to usual treatment.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote